• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Annick D. Van den Abbeele, MD, FACR


  • Hodi FS, Lawrence D, Lezcano C, Wu X, Zhou J, Sasada T, Zeng W, Giobbie-Hurder A, Atkins MB, Ibrahim N, Friedlander P, Flaherty KT, Murphy GF, Rodig S, Velazquez EF, Mihm MC, Russell S, DiPiro PJ, Yap JT, Ramaiya N, Van den Abbeele AD, Gargano M, McDermott D.Bevacizumab plus ipilimumab in patients with metastatic melanoma.Cancer Immunol Res. 2014 Jul(7):632-42.
  • Krajewski KM, Franchetti Y, Nishino M, Fay AP, Ramaiya N, Van den Abbeele AD, Choueiri TK.10% Tumor Diameter Shrinkage on the First Follow-Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitors: A Follow-Up Validation Study.Oncologist. 2014 Apr 22.
  • Mayer IA, Abramson VG, Isakoff SJ, Forero A, Balko JM, Kuba MG, Sanders ME, Yap JT, Van den Abbeele AD, Li Y, Cantley LC, Winer E, Arteaga CL.Stand up to cancer phase ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.J Clin Oncol. 2014 Apr 20;32(12):1202-9.
  • Krajewski KM, Nishino M, Franchetti Y, Ramaiya NH, Van den Abbeele AD, Choueiri TK.Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.Cancer. 2014 Mar 1;120(5):711-21.
  • O'Regan K, Breen M, Ramaiya N, Jagannathan J, DiPiro PJ, Hodi FS, Van den Abbeele AD.Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence.Cancer Imaging. 2013;13(4):626-32.
  • Pyo J, Won Kim K, Jacene HA, Sakellis CG, Brown JR, Van den Abbeele AD.End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.Clin Cancer Res. 2013 Dec 1;19(23):6566-77.
  • Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD.What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.Radiographics.;33(7):2003-17.
  • Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, Friedlander P, Gonzalez R, Weber JS, Gajewski TF, O'Day SJ, Kim KB, Lawrence D, Flaherty KT, Luke JJ, Collichio FA, Ernstoff MS, Heinrich MC, Beadling C, Zukotynski KA, Yap JT, Van den Abbeele AD, Demetri GD, Fisher DE.Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.J Clin Oncol. 2013 Sep 10;31(26):3182-90.
  • Vinjamoori AH, Jagannathan JP, Shinagare AB, Taplin ME, Oh WK, Van den Abbeele AD, Ramaiya NH.Atypical metastases from prostate cancer: 10-year experience at a single institution.AJR Am J Roentgenol. 2012 Aug;199(2):367-72.
  • Halasz LM, Jacene HA, Catalano PJ, Van den Abbeele AD, Lacasce A, Mauch PM, Ng AK.Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e647-54.
  • George S, Wang Q, Heinrich MC, Corless CL, Zhu M, Butrynski JE, Morgan JA, Wagner AJ, Choy E, Tap WD, Yap JT, Van den Abbeele AD, Manola JB, Solomon SM, Fletcher JA, von Mehren M, Demetri GD.Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.J Clin Oncol. 2012 Jul 1;30(19):2401-7.
  • Shinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, Van den Abbeele AD.Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location.J Comput Assist Tomogr.;35(2):217-22.
  • Nishino M, Jackman DM, Hatabu H, Jänne PA, Johnson BE, Van den Abbeele AD.Imaging of lung cancer in the era of molecular medicine.Acad Radiol. 2011 Apr;18(4):424-36.
  • Shinagare AB, Guo M, Hatabu H, Krajewski KM, Andriole K, Van den Abbeele AD, Dipiro PJ, Nishino M.Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.Cancer. 2011 Feb 11.
  • Krajewski KM, Guo M, Van den Abbeele AD, Yap J, Ramaiya N, Jagannathan J, Heng DY, Atkins MB, McDermott DF, Schutz FA, Pedrosa I, Choueiri TK.Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Advanced Renal Cell Carcinoma.Eur Urol. 2011 Feb 1.
  • Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin ME, Van den Abbeele AD.Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.AJR Am J Roentgenol. 2011 Jan;196(1):117-22.
  • Nishino M, Guo M, Jackman DM, DiPiro PJ, Yap JT, Ho TK, Hatabu H, Jänne PA, Van den Abbeele AD, Johnson BE.CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.Acad Radiol. 2011 Jan;18(1):54-62.
  • Hall MN, Jagannathan JP, Ramaiya NH, Shinagare AB, Van den Abbeele AD.Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.AJR Am J Roentgenol. 2010 Nov;195(5):1057-65.
  • Shinagare AB, Jagannathan JP, Ramaiya NH, Hall MN, Van den Abbeele AD.Adult extragonadal germ cell tumors.AJR Am J Roentgenol. 2010 Oct;195(4):W274-80.
  • Nishino M, Jackman DM, Hatabu H, Yeap BY, Cioffredi LA, Yap JT, Jänne PA, Johnson BE, Van den Abbeele AD.New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.AJR Am J Roentgenol. 2010 Sep;195(3):W221-8.
  • Lee AI, Zuckerman DS, Van den Abbeele AD, Aquino SL, Crowley D, Toomey C, Lacasce AS, Feng Y, Neuberg DS, Hochberg EP.Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.Cancer. 2010 Aug 15;116(16):3835-42.
  • Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD.Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.AJR Am J Roentgenol. 2010 Aug;195(2):281-9.
  • Sher DJ, Mauch PM, Van Den Abbeele A, Lacasce AS, Czerminski J, Ng AK.Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.Ann Oncol. 2009 Nov;20(11):1848-53.
  • Demetri GD, Heinrich MC, Fletcher JA, Fletcher CD, Van den Abbeele AD, Corless CL, Antonescu CR, George S, Morgan JA, Chen MH, Bello CL, Huang X, Cohen DP, Baum CM, Maki RG.Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.Clin Cancer Res. 2009 Sep 15;15(18):5902-9.
  • Souza FF, Otero HJ, Erturk M, Rybicki FJ, Ramaiya N, Van den Abbeele AD, Di Salvo DN.Venous thrombosis in an outpatient oncologic center: distribution, type, and comorbidities.Ultrasound Q. 2009 Sep;25(3):145-50.
  • Otero HJ, Jagannathan JP, Prevedello LM, Johnston CJ, Ramaiya NH, Van den Abbeele AD, DiPiro PJ.CT and PET/CT findings of T-cell lymphoma.AJR Am J Roentgenol. 2009 Aug;193(2):349-58.
  • Otero HJ, Yap JT, Patak MA, Erturk SM, Israel DA, Johnston CJ, Sakellis C, Rybicki FJ, Van den Abbeele AD, Ros PR.Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.AJR Am J Roentgenol. 2009 Aug;193(2):326-32.
  • George S,Merriam P,Maki RG,Van den Abbeele AD,Yap JT,Akhurst T,Harmon DC,Bhuchar G,O'Mara MM,D'Adamo DR,Morgan J,Schwartz GK,Wagner AJ,Butrynski JE,Demetri GD,Keohan ML.Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas.J Clin Oncol. 2009 Jul 1;27(19):3154-60.
  • Sheehy N,Kulke MH,Van den Abbeele AD.F-18 FDG PET/CT in the diagnosis and management of a pericardiac paraganglioma.Clin Nucl Med. 2008 Aug;33(8):545-6.
  • Erturk SM,Van den Abbeele AD.Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease.J Natl Compr Canc Netw. 2008 Jul;6(6):623-32. Review.
  • Friedberg J, Jacobsen E, Neuberg D, Kutok J, Munoz O, Boussiotis V, Reynolds H, Fisher D, Szot A, Van Den Abbeele A, Freedman A.Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept.Leuk Lymphoma. 2008 May;49(5):902-9.
  • Hodi FS, Friedlander P, Corless CL, Heinrich MC, Mac Rae S, Kruse A, Jagannathan J, Van den Abbeele AD, Velazquez EF, Demetri GD, Fisher DE.Major response to imatinib mesylate in KIT-mutated melanoma.J Clin Oncol. 2008 Apr 20;26(12):2046-51.
  • Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW, Li X, Gelman R, Burstein HJ, Kasparian E, Kirsch DG, Crawford A, Hochberg F, Winer EP.Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.J Clin Oncol. 2008 Apr 20;26(12):1993-9.
  • Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri S, Connell B, Xie W, Tai YT, Szot-Barnes A, Tian M, Schlossman RL, Weller E, Munshi NC, Van Den Abbeele AD, Anderson KC.Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.Clin Cancer Res. 2008 Apr 15;14(8):2387-95.
  • Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE.F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.JAMA. 2008 Mar 19;299(11):1315-9.
  • Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, Woulfe K, Pravda E, Cassiola F, Desai J, George S, Morgan JA, Harris DM, Ismail NS, Chen JH, Schoen FJ, Van den Abbeele AD, Demetri GD, Force T, Chen MH.Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.Lancet. 2007 Dec 15;370(9604):2011-9.
  • Holdsworth CH, Badawi RD, Manola JB, Kijewski MF, Israel DA, Demetri GD, Van den Abbeele AD.CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.AJR Am J Roentgenol. 2007 Dec;189(6):W324-30.
  • El Fakhri G, Santos PA, Badawi RD, Holdsworth CH, Van Den Abbeele AD, Kijewski MF.Impact of Acquisition Geometry, Image Processing, and Patient Size on Lesion Detection in Whole-Body 18F-FDG PET.J Nucl Med. 2007 Dec;48(12):1951-1960.
  • Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE.Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.Clin Cancer Res. 2007 Oct 15;13(20):6175-81.
  • Desai J, Shankar S, Heinrich MC, Fletcher JA, Fletcher CD, Manola J, Morgan JA, Corless CL, George S, Tuncali K, Silverman SG, Van den Abbeele AD, van Sonnenberg E, Demetri GD.Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5398-405.
  • Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J.NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.J Natl Compr Canc Netw. 2007 Jul;5 Suppl 2:S1-29; quiz S30. Review.
  • Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D,.Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.J Nucl Med. 2006 Jun;47(6):1059-66.
  • Burrell SC, Van den Abbeele AD.2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants.Mol Imaging Biol. 2005 May-Jun;7(3):244-56.
  • Shankar S, vanSonnenberg E, Desai J, Dipiro PJ, Van Den Abbeele A, Demetri GD.Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate.Radiology. 2005 Jun;235(3):892-8.
  • Ng AK, Bernardo MV, Silver B, Van Den Abbeele A, Stevenson MA, Fisher DC, Mauch PM.Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):175-84.
  • McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Posner MR, Van den Abbeele AD.Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.Head Neck. 2004 Oct;26(10):890-6.
  • Heymach JV, Desai J, Manola J, Davis DW, McConkey DJ, Harmon D, Ryan DP, Goss G, Quigley T, Van den Abbeele AD, Silverman SG, Connors S, Folkman J, Fletcher CD, Demetri GD.Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas.Clin Cancer Res. 2004 Sep 1;10(17):5732-40.
  • Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD.FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.Leuk Lymphoma. 2004 Jan;45(1):85-92.
  • Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA.Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.J Clin Oncol. 2003 Dec 1;21(23):4342-9.
  • Van den Abbeele AD, Badawi RD.Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).Eur J Cancer. 2002 Sep;38 Suppl 5:S60-5.
  • Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med. 2002 Aug 15;347(7):472-80.
  • Losken A, Swartz MA, Van Den Abbeele AD, Jain RK, Slavin SA.A potential murine model for flap-related investigations.Plast Reconstr Surg. 2001 May;107(6):1504-8.
  • Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD.Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.Cancer. 2001 Jan 1;91(1):17-24.
  • Frank DA, Meuse J, Hirsch D, Ibrahim JG, van den Abbeele AD.The treatment and outcome of cancer patients with thromboses on central venous catheters.J Thromb Thrombolysis. 2000 Dec;10(3):271-5.
  • Frohlich DE, Chen JL, Neuberg D, Kehoe KM, Van den Abbeele AD.When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?.J Nucl Med. 2000 Feb;41(2):269-74.
  • Friedberg JW, Van den Abbeele AD, Kehoe K, Singer S, Fletcher CD, Demetri GD.Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma.Cancer. 1999 Oct 15;86(8):1621-7.
  • Slavin SA, Van den Abbeele AD, Losken A, Swartz MA, Jain RK.Return of lymphatic function after flap transfer for acute lymphedema.Ann Surg. 1999 Mar;229(3):421-7.
  • Wu C, Vasconcelles M, DePiro P, Van den Abbeele A, Rakusin A, Bechard K, Skarin A.Primary cardiac angiosarcoma presenting as a malignant pericardial effusion.J Clin Oncol. 1998 Dec;16(12):3913-5.
  • Kassis AI, Wen PY, Van den Abbeele AD, Baranowska-Kortylewicz J, Makrigiorgos GM, Metz KR, Matalka KZ, Cook CU, Sahu SK, Black PM, Adelstein SJ.5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.J Nucl Med. 1998 Jul;39(7):1148-54.
  • Bartold SP, Donohoe KJ, Fletcher JW, Haynie TP, Henkin RE, Silberstein EB, Royal HD, Van den Abbeele A.Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine.J Nucl Med. 1997 Jun;38(6):990-4.
  • Slavin SA, Upton J, Kaplan WD, Van den Abbeele AD.An investigation of lymphatic function following free-tissue transfer.Plast Reconstr Surg. 1997 Mar;99(3):730-41; discussion 742-3.
  • Kassis AI, Tumeh SS, Wen PY, Baranowska-Kortylewicz J, Van den Abbeele AD, Zimmerman RE, Carvalho PA, Garada BM, DeSisto WC, Bailey NO, Castronovo FP, Mariani G, Black PM, Adelstein SJ.Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.J Nucl Med. 1996 Apr;37(4 Suppl):19S-22S.
  • Van den Abbeele AD, Tutrone RF, Berman RM, Baranowska-Kortylewicz J, Barclay PD, Richie JP, Adelstein SJ, Kassis AI.Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.J Nucl Med. 1996 Feb;37(2):315-20.
  • Gangopadhyay A, Saravis CA, van den Abbeele AD, Kassis AI.pI-dependent isolation of antibody isoforms by semipreparative isoelectric focusing.Q J Nucl Med. 1995 Jun;39(2):129-33.
  • Mariani G, Collecchi P, Giuliani L, Baranowska-Kortylewicz J, Di Luca L, Meucci G, Viacava P, Van den Abbeele AD, Salvadori PA, Di Sacco S.Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.Ann N Y Acad Sci. 1993 Nov 30;698:204-11.
  • Mariani G, Cei A, Collecchi P, Baranowska-Kortylewicz J, Van den Abbeele AD, Di Luca L, Di Stefano R, Viacava P, Ferdeghini EM, Di Sacco S.Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.J Nucl Med. 1993 Jul;34(7):1175-83.
  • Khawli LA, van den Abbeele AD, Kassis AI.N-(m-[125I]iodophenyl)maleimide: an agent for high yield radiolabeling of antibodies.Int J Rad Appl Instrum B. 1992 Apr;19(3):289-95.
  • Baranowska-Kortylewicz J, Makrigiorgos GM, Van den Abbeele AD, Berman RM, Adelstein SJ, Kassis AI.5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model.Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1541-51.
  • Janicek MJ, Van den Abbeele AD, DeSisto WC, Kassis AI, Holman BL, Tumeh SS, Hollenberg NK.Embolization of platelets after endothelial injury to the aorta in rabbits. Assessment with 111indium-labeled platelets and angiography.Invest Radiol. 1991 Jul;26(7):655-9.
  • Mariani G, Ito S, Nayak RC, Baranowska-Kortylewicz J, Venkateshan CN, Van den Abbeele AD, Eisenbarth GS, Adelstein SJ, Kassis AI.Capping and internalization of a monoclonal antibody-surface antigen complex: a possible mode of interaction of monoclonal antibodies and tumor cells.J Nucl Biol Med. 1991 Apr-Jun;35(2):111-9.
  • Tumeh SS, Carvalho PA, van den Abbeele AD, Maguire JH, Rauh DA, Neptune M, Kassis AI.Detection of focal infection by 111In-human polyclonal IgG.J Nucl Biol Med. 1991 Jan-Mar;35(1):4-9.
  • Van den Abbeele AD, Aaronson RA, Daher S, Taube RA, Adelstein SJ, Kassis AI.Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.J Nucl Med. 1991 Jan;32(1):116-22.
  • Adelstein SJ, Kassis AI, Baranowska-Kortylewicz J, van den Abbeele AD, Mariani G, Ito S.Potential for tumor therapy with iodine-125 labeled immunoglobulins.Int J Rad Appl Instrum B. 1991;18(1):43-4.
  • Janicek MJ, Van den Abbeele AD, Hollenberg NK, Kassis AI, Holman BL, Tumeh SS.Platelet activation and aggregation after endothelial injury. Assessment with indium-111-labeled platelets and angiography.Invest Radiol. 1990 Sep;25(9):988-93.
  • Kassis AI, Van den Abbeele AD, Wen PY, Baranowska-Kortylewicz J, Aaronson RA, DeSisto WC, Lampson LA, Black PM, Adelstein SJ.Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.Cancer Res. 1990 Aug 15;50(16):5199-203.
  • Makrigiorgos GM, Ito S, Baranowska-Kortylewicz J, Vinter DW, Iqbal A, Van den Abbeele AD, Adelstein SJ, Kassis AI.Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications.J Nucl Med. 1990 Aug;31(8):1358-63.
  • Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG.Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.Cancer Res. 1990 Apr 1;50(7):2198-202.
  • van den Abbeele AD, Aaronson RA, Taube RA, Adelstein SJ, Kassis AI.Preadsorption of radiolabeled monoclonal antibodies to liver and spleen tissues leads to higher tumor-to-normal-tissue ratios.J Nucl Med Allied Sci. 1990 Apr-Jun;34(2):94-102.
  • Muto MG, Lepisto EM, Van den Abbeele AD, Knapp RC, Kassis AI.Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.Am J Obstet Gynecol. 1989 Nov;161(5):1206-12.
  • Kinsey BM, Van den Abbeele AD, Adelstein SJ, Kassis AI.Absence of preferential uptake of [125I]iododihydrorhodamine 123 by four human tumor xenografts.Cancer Res. 1989 Nov 1;49(21):5986-8.
  • Van den Abbeele AD, Aaronson RA, Adelstein SJ, Kassis AI.Does the in vitro testing of the immunoreactivity of an antibody reflect its in vivo behavior?.J Nucl Med Allied Sci. 1988 Oct-Dec;32(4):260-7.
  • Layne WW, Kassis AI, Van den Abbeele A, Kinsey BM, Adelstein SJ.HPLC analysis of the dissociation and recombination of rabbit immunoglobulin G.J Immunol Methods. 1987 Feb 11;96(2):195-9.
  • Engelhardt B, Sandberg K, Bratton D, Van den Abbeele A, Grogaard J, Hellerqvist C, Sundell H.The role of granulocytes in the pulmonary response to group B streptococcal toxin in young lambs.Pediatr Res. 1987 Feb;21(2):159-65.
  • Van den Abbeele AD, Treves ST, Lebowitz RL, Bauer S, Davis RT, Retik A, Colodny A.Vesicoureteral reflux in asymptomatic siblings of patients with known reflux: radionuclide cystography.Pediatrics. 1987 Jan;79(1):147-53.
  • Grogaard J, Van den Abbeele A, Sundell H.Effect of alcohol on apnea reflexes in young lambs.J Appl Physiol. 1985 Aug;59(2):420-5.